Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
The Science of the Total Environment|March 5, 2002
Exchange of organic solvents between the atmosphere and grass--the use of open top chambersJ Binnie, J N Cape, N Mackie, et al.
Poultry Science|February 22, 2023
Fear, anxiety, and production in laying hens with healed keel bone fracturesJ L Edgar, Y Omi, F Booth, et al.
Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission|November 25, 2010
Tape transfer sectioning of tissue microarrays introduces nonspecific immunohistochemical staining artifactsD Catchpoole, N Mackie, S McIver, et al.
Vaccine|May 3, 2008
Participation in two phase II prophylactic HIV vaccine trials in the UKKimberly Gray, K Legg, A Sharp, et al.
Journal of Applied Research in Intellectual Disabilities : JARID|December 20, 2016
Quantitative Measurement of Communication Ability in Children with Angelman SyndromeJoseph C Grieco, Ruth H Bahr, Mike R Schoenberg, et al.
The Journal of Orthopaedic and Sports Physical Therapy|November 8, 2016
Optimism Moderates the Influence of Pain Catastrophizing on Shoulder Pain Outcome: A Longitudinal AnalysisRogelio A Coronado, Corey B Simon, Trevor A Lentz, et al.
Maternal and Child Health Journal|April 18, 2016
Application of Implementation Science Methodology to Immediate Postpartum Long-Acting Reversible Contraception Policy Roll-Out Across StatesKristin M Rankin, Charlan D Kroelinger, Carla L DeSisto, et al.
Implementation Science : IS|November 23, 2017
Using a multi-state Learning Community as an implementation strategy for immediate postpartum long-acting reversible contraceptionCarla L DeSisto, Cameron Estrich, Charlan D Kroelinger, et al.
Contemporary Clinical Trials|March 19, 2017
Biopsychosocial influence on shoulder pain: Rationale and protocol for a pre-clinical trialSteven Z George, Roland Staud, Paul A Borsa, et al.
HIV Medicine|November 21, 2008
The associations between age and the development of laboratory abnormalities and treatment discontinuation for reasons other than virological failure in the first year of highly active antiretroviral therapyC A Sabin, C J Smith, V Delpech, et al.
Pageof 2